McQuade Center for Strategic Research & Development

The McQuade Center for Strategic Research & Development (MSRD) is a strategic drug development and investment organization within the Otsuka family of companies. Founded in 2019, MSRD is dedicated to identifying and supporting early-stage research and development programs, typically ranging from discovery through Phase 2 clinical trials. The center focuses on high-potential therapeutic candidates in the fields of mental health and renal disorders, providing both financial investment and technical R&D expertise. By leveraging Otsuka's global infrastructure, MSRD aims to accelerate the development of innovative treatments for patients with significant unmet medical needs. The organization operates through a collaborative model, partnering with biotechnology companies and academic institutions to advance a diverse portfolio of psychiatric, neurological, and nephrological assets.